CRP and chronic obstructive pulmonary disease: In particular, Eickhoff et al. observed a reduction of FMD values in relation to the increase of circulating inflammatory biomarkers (e.g., CRP, fibrinogen, interleukin-6) in patients affected by stable COPD, thus underlining a significant and dangerous association between airway obstruction, inflammation, ED and, therefore, cardiovascular risk (56).